Replimune Group Stock Market Value
| REPL Stock | USD 11.05 0.18 1.60% |
| Symbol | Replimune |
Replimune Group Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.04) | Return On Assets (0.27) | Return On Equity (0.50) |
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Replimune 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Replimune's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Replimune.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Replimune on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Replimune Group or generate 0.0% return on investment in Replimune over 360 days. Replimune is related to or competes with Nuvalent, Ventyx Biosciences, Ascendis Pharma, United Therapeutics, Nuvectis Pharma, Lyra Therapeutics, and Kronos Bio. Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer More
Replimune Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Replimune's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Replimune Group upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.61 | |||
| Information Ratio | 0.0173 | |||
| Maximum Drawdown | 15.63 | |||
| Value At Risk | (5.60) | |||
| Potential Upside | 7.23 |
Replimune Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Replimune's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Replimune's standard deviation. In reality, there are many statistical measures that can use Replimune historical prices to predict the future Replimune's volatility.| Risk Adjusted Performance | 0.0453 | |||
| Jensen Alpha | 0.0354 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.0165 | |||
| Treynor Ratio | 0.1279 |
Replimune Group Backtested Returns
As of now, Replimune Stock is somewhat reliable. Replimune Group maintains Sharpe Ratio (i.e., Efficiency) of 0.049, which implies the firm had a 0.049% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Replimune Group, which you can use to evaluate the volatility of the company. Please check Replimune's Semi Deviation of 3.28, risk adjusted performance of 0.0453, and Coefficient Of Variation of 2035.48 to confirm if the risk estimate we provide is consistent with the expected return of 0.17%. Replimune has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 1.24, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Replimune will likely underperform. Replimune Group right now holds a risk of 3.48%. Please check Replimune Group value at risk, as well as the relationship between the skewness and day median price , to decide if Replimune Group will be following its historical price patterns.
Auto-correlation | -0.63 |
Very good reverse predictability
Replimune Group has very good reverse predictability. Overlapping area represents the amount of predictability between Replimune time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Replimune Group price movement. The serial correlation of -0.63 indicates that roughly 63.0% of current Replimune price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.63 | |
| Spearman Rank Test | -0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 2.84 |
Replimune Group lagged returns against current returns
Autocorrelation, which is Replimune stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Replimune's stock expected returns. We can calculate the autocorrelation of Replimune returns to help us make a trade decision. For example, suppose you find that Replimune has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Replimune regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Replimune stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Replimune stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Replimune stock over time.
Current vs Lagged Prices |
| Timeline |
Replimune Lagged Returns
When evaluating Replimune's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Replimune stock have on its future price. Replimune autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Replimune autocorrelation shows the relationship between Replimune stock current value and its past values and can show if there is a momentum factor associated with investing in Replimune Group.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Replimune Correlation, Replimune Volatility and Replimune Alpha and Beta module to complement your research on Replimune. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Replimune technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.